Folashade Otegbeye, MBChB, MPH

/content/dam/www/faculty-photos/O/folashade-otegbeye/folashade-otegbeye.jpg
Dr. Folashade  Otegbeye MBChB, MPH
Faculty Member

Folashade Otegbeye, MBChB, MPH

Associate Professor, Translational Science and Therapeutics, Fred Hutch

Associate Professor
Translational Science and Therapeutics, Fred Hutch

Facility Director, Therapeutic Products Program, Fred Hutch

Facility Director, Therapeutic Products Program
Fred Hutch

Mail Stop: D5-310

Dr. Folashade Otegbeye is a clinical researcher who specializes in blood stem cell transplantation for blood cancers and other diseases of blood and marrow. In her lab, she studies the immunology of transplant and immune cell therapy for a variety of cancers. In her role as facility director of the Hutch’s Therapeutic Products shared resource, she works with the Hutch’s cellular immunotherapy labs to translate their research ideas into clinical products. Her research in the clinic is aimed at improving transplant care for people with bone marrow failure syndromes and myeloproliferative disorders, in which blood cells grow abnormally in the marrow.

Other Appointments & Affiliations

Affiliate Investigator, Clinical Research Division, Fred Hutch

Affiliate Investigator
Clinical Research Division, Fred Hutch

Associate Professor, University of Washington School of Medicine

Associate Professor
University of Washington School of Medicine

Education

Hematology and Oncology Fellowship, University Hospitals Cleveland Medical Center; Case Western Reserve University, 2016

Internal Medicine Internship & Residency, Bridgeport Hospital Yale New Haven Health, 2013

MPH, Harvard School of Public Health, 2009

MBChB, Obafemi Awolowo University Ile-Ife, 2005

Research Interests

Natural killer cells and other immune effector cell therapy

Post-transplant immune reconstitution

Haploidentical and cord blood transplantation

Clinical Expertise

Immune effector cell therapy

Hematopoietic cell transplantation for bone marrow failure syndromes

Hematopoietic cell transplantation for myelofibrosis

Acute myeloid leukemia and myelodysplastic syndrome

Acute lymphoblastic leukemia

"In blood cancer transplantation, we have a lot of ongoing, frequent interactions with patients and their family members or caregivers. I’ve always been inspired, and touched, by those relationships."

— Dr. Folashade Otegbeye

Find a Clinical Trial